Functional differences among multiple isoforms of guinea pig decay- accelerating factor

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 3014-3022

  Wang, Guixian ^a,b   Nonaka, Mayumi ^b   He, Changqing ^b   Okada, Noriko ^b   Nakashima, Izumi ^a   Okada, Hidechika ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; COMPLEMENT COMPONENT C3; COMPLEMENTARY DNA; DECAY ACCELERATING FACTOR;

ANIMAL CELL; ARTICLE; CHO CELL; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; GENE STRUCTURE; GUINEA PIG; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ANIMALS; ANTIGENS, CD55; BLOTTING, WESTERN; CHO CELLS; COMPLEMENT C3; COMPLEMENT PATHWAY, ALTERNATIVE; CRICETINAE; FEMALE; GLYCOSYLPHOSPHATIDYLINOSITOLS; GUINEA PIGS; MALE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0032520780     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Okada, H., H. Tanaka, and N. Okada. 1983. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes. Eur. J. Immunol. 13:340.
2. Medof, M. E., T. Kinoshita, and V. Nussenzweig. 1984. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160:1558.
3. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35.
4. Carroll, M. C., E. M. Alicot, P. J. Katzman, L. B. Klickstein, J. A. Smith, and D. T. Fearon. 1988. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1. J. Exp. Med. 167:1271.
5. Rey-Campos, J., P. Rubenslein, and S. Rodriquez De Cordoba. 1988. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J. Exp. Med. 167:664.
6. Hourcade, D., A. D. Garcia, T. W. Post, P. Taillon-Miller, V. M. Holers, L. M. Wagner, N. S. Bora, and J. P. Alkinson. 1992. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics 12:289.
7. Caras, I. M., M. A. Davitz, L. Rhee, G. Weddell, D. W. Martin, and V. Nussenzweig. 1987. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545.
8. Medof, M. E., D. M. Lublin, V. M. Holers, D. J. Ayers, R. R. Getty, J. F. Leykam, J. P. Atkinson, and M. L. Tykocinski. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84:2007.
9. Moran, P., H. Beasley, A. Gorrel, E. Martin, P. Gribling, H. Fuchs, N. Gilett, L. E. Burton, and I. W. Caras. 1992. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J. Immunol. 149:1716.
10. Okada, N., R. Harada, T. Fujita, and H. Okada. 1989. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1:205.
11. Davies, A., D. L. Simmons, G. Hale, R. A. Harrison, H. Tigh, P. L. Lachmann, and H. Waldmann. 1989. CD59, an Ly-6-like protein expressed in human lymphoid cells regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170:637.
12. Pangburn, M. K., R. D. Schreiber, and H. J. Muller-Eberhard. 1983. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmalnocturnal hemoglobinuria. Proc. Nat. Acad. Sci. USA 80:5430.
13. Okada, N., R. Harada, and H. Okada. 1990. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor. Clin. Exp. Immunol. 80: 109.
14. Dalmasso, A. P., G. M. Vercellotti, J. L. Platt, and F. H. Bach. 1991. Inhibition of complement-mediated endothelial cell cytotoxicily by decay-accelerating factor. Transplantation 52:530.
15. Cozzi, F., and D. J. G. White. 1995. The generation ot transgenic pigs as potential organ donors for humans. Nat. Med. 1:964.
16. Hamann, J., B. Vogel, G. M. W. van Schijndel, and R. A. W. van Lier. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1185.
17. Cheung, N.-K. V., E. I. Walter, W. H. Smith-Mensah, W. D. Ratnoff, M. L. Tykocinski, and M. E. Medof. 1988. Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J. Clin. Invest. 81:1122.
18. Bjørge, L., T. S. Jensen, and R. Matre. 1996. Characterization of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane co-factor protein (MCP, CD46) on a human colonie adenocarcinoma cell line. Cancer Immunol. Immunother. 42:185.
19. Bergelson, J. M., M. Chan, K. R. Solomon, N. F. St. John, H. Lin, and R. W. Finberg. 1994. Decay accelerating factor (CD55), a glycosylphosphatidy-linositol-anchored complement regulatory protein, is a receptor for several echo-viruses. Proc. Natl. Acad. Sci. USA 91:6245.
20. Ward, T., P. A. Pipkin, N. A. Clarkson, D. M. Stone, P. D. Minor, and J. W. Almond. 1994. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13:5070.
21. Okada, N., H. Tanaka, H. Takizawa, and H. Okada. 1995. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor. J. Immunol. 154:6103.
22. Nonaka, M., T. Miwa, N. Okada, M. Nonaka, and H. Okada. 1995. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. J. Immunol. 155:3037.
23. Thomas, P. S. 1983. Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods Enzymol. 100:255.
24. Fuhlbrigge, R. C., S. M. Fine, E. R. Unanue, and D. D. Chaplin. 1988. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc. Natl. Acad. Sci. USA 85:5649.
25. Cervoni, F., T. J. Oglesby, P. Fénichel, G. Dohr, B. Rossi, J. P. Atkinson, and B.-L. Hsi. 1993. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J. Immunol. 151:939.
26. Spicer, A. P., M. F. Seldin, and S. J. Gendler. 1995. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J. Immunol. 155:3079.
27. Asch, A. S., T. Kinoshita, E. A. Jaffe, and V. Nussenzweig. 1986. Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J. Exp. Med. 163:221.
28. Medof, M. E., E. I. Walter, J. L. Rutgers, D. M. Knowles, and V. Nussenzweig. 1987. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165:848.
29. Johnstone, R. W., S. M. Russell, B. E. Loveland, and I. F. C. McKenzie. 1993. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol. Immunol. 30:1231.
30. Hosokawa, M., M. Nonaka, N. Okada, M. Nonaka, and H. Okada. 1996. Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis. J. Immunol. 157:4946.
31. Aegerter-Shaw, M., J. L. Cole, L. B. Klickstein, W. W. Wong, D. T. Fearon, P. A. Lalley, and J. H. Weis. 1987. Expansion of the complement receptor gene family: identification in the mouse of two new genes related to the CR1 and CR2 gene family. J. Immunol. 138:3488.
32. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
33. Song, W. C., C. Deng, K. Raszmann, R. Moore, R. Newbold, J. A. McLachlan, and M. Negishi. 1996. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J. Immunol. 157:4166.
34. Lublin, D. M., and K. E. Coyne. 1991. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J. Exp. Med. 174:35.
35. Coyne, K. E., S. E. Hall, E. S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149:2906.
36. Liszewski, M. K., and J. P. Atkinson. 1996. Membrane cofactor protein (MCP; CD46): isoforms differ in protection against the classical pathway of complement. J. Immunol. 156:4415.
37. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431.
38. Anderson, D. J., A. F. Abbott, and R. M. Jack. 1993. The role of complement component C3b and its receptors in sperm-oocyte interaction. Proc. Natl. Acad. Sci. USA 90:10051.
39. Nonaka, M., M. Nonaka, O. Takenaka, N. Okada, and H. Okada. 1998. A novel repetitive sequence uniquely present in the decay-accelerating factor genes. Immunogenetics 47:246.